Buy GHRP-6 (5mg x 10) and Mod GRF 1-29 (5mg x 10) – USA & Europe

1. What is the GHRP-6 and Mod GRF 1-29 combination

GHRP-6 and Mod GRF 1-29 are peptides that synergistically stimulate natural growth hormone (GH) release through different mechanisms:

• Mod GRF 1-29 (also known as CJC-1295 no DAC) is a synthetic analog of growth hormone releasing hormone (GHRH). It binds to GHRH receptors in the pituitary to stimulate GH secretion in a pulsatile manner resembling natural hormone release.

• GHRP-6 binds to ghrelin receptors (GHS-R1a) in the pituitary, enhancing GH pulse amplitude and frequency and also increasing appetite.

The blend of these two results in a significantly enhanced pulsatile release of GH, improving muscle growth, fat metabolism, bone density, recovery, and overall anti-aging effects.

2. Substances contained

Ten vials of 5mg pharmaceutical-grade GHRP-6 and ten vials of 5mg pharmaceutical-grade Mod GRF 1-29 peptides for subcutaneous injection.

3. Suitable for

Adults who want to increase lean muscle mass, reduce body fat, enhance recovery from training or injury, improve sleep quality, boost bone health, and support anti-aging.

4. Before starting

Consult a healthcare professional to determine dosing and assess health status. Avoid if pregnant, breastfeeding, or with hormone-sensitive conditions.

5. Contraindications

Pregnancy, breastfeeding, hormone-dependent cancer, or serious illness.

6. Interactions

No significant drug or food interactions; benefits enhanced with healthy lifestyle.

7. Overdose

Seek immediate medical attention if adverse symptoms develop.

8. Monitoring

Regular blood tests for GH, IGF-1, glucose are recommended during use.

9. Prescription

Medical supervision generally required.

10. Legal status

Varies; often prescription-only for clinical use.

11. Safety

Generally well tolerated; injection site reactions, hunger, mild headaches possible.

12. Pre-existing conditions

Consult healthcare provider if present.

13. Allergies

Avoid if allergic to peptide components.

14. Medications

Disclose all ongoing medications.

15. Pregnancy

Use only with medical supervision.

16. Administration

Administer by subcutaneous injection, usually 1-3 times daily.

17. Best use

Inject before bedtime or workouts; maintain consistent use with supportive diet and exercise.

18. Effectiveness

Research indicates synergistic stimulation of GH release, leading to increased muscle mass, fat loss, improved bone density, and recovery support.

19. Side effects

Possible injection reactions, increased appetite, headaches, dizziness.

20. Severe side effects

Stop use and seek medical help immediately.

21. Alcohol

Limit consumption during peptide therapy.

22. Missed dose

Take dose as soon as possible or skip if near next dose; avoid doubling dose.

23. Duration

Typical protocol cycles 4-12 weeks.

24. Post-treatment

GH levels normalize; benefits diminish without ongoing use.

25. Withdrawal

Not reported.

26. Storage

Store refrigerated at 2-8°C, shield from light.

27. Alternatives

Other GH secretagogues include Ipamorelin, GHRP-2, Hexarelin, CJC-1295 DAC.